Neoadjuvant Systemic Treatment of Primary Angiosarcoma

Angiosarcoma is an extremely rare and aggressive malignancy. Standard of care of localized tumors includes surgery ± radiation. Despite this multimodal treatment, >50% of the angiosarcoma patients develop local or distant recurrent disease. The role of neoadjuvant systemic therapy is still contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinhuis, Kimberley M., IJzerman, Nikki S., van der Graaf, Winette T. A., Kerst, Jan Martijn, Schrage, Yvonne, Beijnen, Jos H., Steeghs, Neeltje, van Houdt, Winan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464310/
https://www.ncbi.nlm.nih.gov/pubmed/32806524
http://dx.doi.org/10.3390/cancers12082251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464310/
https://www.ncbi.nlm.nih.gov/pubmed/32806524
http://dx.doi.org/10.3390/cancers12082251

Ejemplares similares